TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96,140 | -66.3% | 11,500 | 0.0% | 0.09% | -64.9% |
| Q2 2023 | $285,660 | +65.2% | 11,500 | 0.0% | 0.26% | +58.9% |
| Q1 2023 | $172,960 | +27.1% | 11,500 | 0.0% | 0.16% | +19.9% |
| Q4 2022 | $136,045 | +70.1% | 11,500 | -14.8% | 0.14% | +78.9% |
| Q3 2022 | $80,000 | +40.4% | 13,500 | 0.0% | 0.08% | +31.0% |
| Q2 2022 | $57,000 | -58.7% | 13,500 | -6.9% | 0.06% | -53.6% |
| Q1 2022 | $138,000 | -50.0% | 14,500 | 0.0% | 0.12% | -48.6% |
| Q4 2021 | $276,000 | -42.9% | 14,500 | 0.0% | 0.24% | -43.0% |
| Q3 2021 | $483,000 | -14.1% | 14,500 | 0.0% | 0.43% | -13.4% |
| Q2 2021 | $562,000 | – | 14,500 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |